Skip to Content
Pharmaceutical company Merck fell six spots on the list in its first year with CEO Robert Davis at the helm. But that modest slide masks a successful year in which profits jumped 85%, to $13 billion. Excluding revenue from Organon, the women’s health company whose spinoff was completed in June 2021, Merck’s sales overall increased 17%, including a 20% gain for the company’s hallmark cancer drug Keytruda and a 44% increase in sales for HPV vaccine Gardasil. Merck also registered nearly $1 billion in sales for molnupiravir, an oral antiviral treatment for COVID that received emergency use authorization from the FDA in December 2021. 
Courtesy of Merck
Lists ranking Merck
RANK262
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MOREview in list
RANK32
35 Best Large Workplaces in New York - 2022The companies on this year's list stand out for ce...READ MOREview in list
RANK71
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MOREview in list
RANK41
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list
RANK100
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
RANK53
Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list